Illumina
Overview

Date:
29th April 2024, Monday

Time:
10:00 am - 11:00 am (Dubai)
11:30 am - 12:30 pm (Delhi)
02:00 pm - 03:00 pm (Singapore)
03:00 pm - 04:00 pm (Seoul / Tokyo)
04:00 pm - 05:00 pm (Melbourne)
06:00 pm - 07:00 pm (Auckland)

Register Now
We understand that our webinar timing may not suit your busy schedule. Please feel free to register to get the on-demand recording link once it is ready.

This support webinar discusses the NextSeq 1000 and 2000 sequencers and reagents, including the introduction of XLEAP-SBS™ chemistry, pre-run considerations, run setup, run start best practices, run metrics review, and maintenance. This webinar is for anyone who wants to learn more about the NextSeq 1000/2000 Run Quality and Best Practices.

Speaker:

Vijay Bhaskarla
Staff Technical Applications Scientist,
Illumina

Vijay graduated from the RMIT University, Australia in 2017 with a PhD in Applied Genomics. His main role as Technical Application Scientist at Illumina is to provide instrumentation and informatics support to Illumina customers in the Asia Pacific region. He has extensive experience in NGS data analysis that includes RNA-Seq, Methylation and Metagenomics.
Register below to join the webinar.
Company Legal
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.